Wilkinson Stekloff Ranked Among 2023 Trial Elite

In recognition of Wilkinson Stekloff’s work on some of the most consequential trials across the antitrust, product liability, and sports landscape, legal industry research outlets Chambers and Partners and The Legal 500 have ranked the firm among the trial elite in their recently released 2023 editions. Chambers has maintained Wilkinson Stekloff’s position as one of the country’s most highly sought litigation boutiques, ranking it for General Commercial Litigation (DC) — The Elite (Band 3) and Product Liability & Mass Torts (USA-Nationwide) – The Elite (Band 4). Chambers also recognized Partners Beth Wilkinson (Star Individual in Trial Lawyers USA-Nationwide, Product Liability & Mass Torts Nationwide, General Commercial, DC, and Sports Law Nationwide, Band 4) and Brian Stekloff (Product Liability & Mass Torts Nationwide, Band 5). Wilkinson Stekloff is also newly noted as a “Firm to Watch” in Antitrust — Civil Litigation/Class Action Defense by The Legal 500, and is newly ranked …

Benchmark Litigation Selects Wilkinson Stekloff as Top 20 Trial Law Firm, and Honors Six Partners

Wilkinson Stekloff has been named a Top 20 Trial Law Firm in the highly anticipated 2023 Benchmark Litigation guide. Along with this prestigious recognition, the firm is also ranked as Tier 1 for General Commercial Litigation and recognized as a Top Boutique and Highly Recommended firm. Benchmark Litigation is considered the definitive guide to the world’s leading litigation firms and lawyers. The rankings are determined through six months of research, which includes extensive interviews with clients. In addition to top-tier firm rankings, Wilkinson Stekloff founding partner Beth Wilkinson was named a Top 100 Trial Lawyer. This elite group consists of partners who have been selected by peers and clients as the best of the best in the practice of trial law, with the representative work to exemplify this status. This recognition comes on the heels of Beth being named a Top 10 Female Litigator by Benchmark Litigation for the second …

Three Wilkinson Stekloff Partners Recognized in the National Law Journal Legal Awards 2022

The National Law Journal has recognized three Wilkinson Stekloff partners in its 2022 Legal Awards. The prestigious annual series highlights the top litigation and appellate work of law firms and attorneys from the previous year.  Wilkinson Stekloff had more individuals distinguished than any other firm. Partners Cali Cope-Kasten and Rakesh Kilaru were both named Rising Stars, while Founding Partner Brian Stekloff is a finalist in the “Winning Litigators” category. The winners will be announced at an awards ceremony in Washington, D.C., on October 20.   Cali made partner in early 2022, fresh off acting as trial counsel to help secure the first win for Monsanto in the Roundup mass tort litigation. She has played a critical role in six jury trials, three of which were federal multi-district litigation bellwether cases, and two bench trials. She has argued numerous motions in state and federal courts at the trial and appellate level and is serving as trial counsel for Monsanto in …

Wilkinson Stekloff Partner Cali Cope-Kasten Featured in Law.com’s “How I Made Partner” Series

For its series asking top-tier lawyers about their path to promotion, Law.com recently featured Wilkinson Stekloff partner Cali Cope-Kasten. Cali reflects on the key to successful business development — “doing excellent work” — and the impact founding partner Beth Wilkinson has made on her development as a trial attorney: “She has been a champion for me and for so many young women at our firm. She helped me develop a reputation with our clients by giving me opportunities early in my career to have a seat at the table in client meetings and encouraging me to stand up and speak up to present my work every chance I got. And watching her engage with judges and juries has been an incredible learning experience that has provided me with inspiration to develop my own style.” Cali made partner in early 2022 following the critical role she played in Clark v. Monsanto …

Business Insider Names Cali Cope-Kasten 2022 Rising Star of the Courtroom

Cali Cope-Kasten has been named a 2022 Rising Star of the Courtroom by Business Insider. The prestigious list profiles 15 up-and-coming litigators who have represented clients in blockbuster trials and class actions around the country. An embodiment of Wilkinson Stekloff’s mission to develop the next generation of trial lawyers, Cali has earned this recognition at the age of 33, years before most of her fellow recipients.     Late last year, Cali played a critical role examining several witnesses in Clark v. Monsanto, the first case involving a child plaintiff in the litigation over whether the herbicide Roundup causes Non-Hodgkin Lymphoma. After a single day of deliberation, a jury delivered the first-ever verdict for Monsanto.  Describing her experience with Business Insider, Cali shared that “jurors told her afterward that her questioning of a weed scientist about how often Roundup was typically used was key to their understanding of the case.” Brian Stekloff, who has known Cali …

D.C. Court of Appeals Affirms Trial Win for First Wilkinson Stekloff Pro Bono Victory of 2022

Cali Cope-Kasten recently won an appeal at the D.C. Court of Appeals affirming her earlier trial win in Brian Macklin v. Janai Johnson, a complex and contentious divorce and child custody case. The appeal followed a five-day trial in D.C. Superior Court at which Cali and the Wilkinson Stekloff team, representing their client pro bono, won primary physical custody of the parties’ five children, tie-breaking authority in legal custody, and a 40% interest in the parties’ marital home.  The Court’s 32-page opinion affirmed Ms. Johnson’s victory on all issues and gives hope to other women in Ms. Johnson’s position, “hold[ing] as a matter of first impression that substantial homemaker services can indeed entitle a spouse to an equitable interest in real property purchased by the other spouse before the marriage and used as the family home.” This is the first pro bono victory of 2022 for the Wilkinson Stekloff team and comes on the heels …

2021 Year In Review

WASHINGTON — In 2021, despite ongoing pandemic-related delays and challenges, the Wilkinson Stekloff team continued to litigate with the intensity and success that has cemented our reputation as the leading trial boutique in the country. In a year where trials remained scarce, WS tried two high-profile cases in 2021:  WS served as lead trial counsel for Altria Group, Inc. in an adversarial administrative proceeding before the FTC. The FTC alleged that Altria and JLI violated antitrust laws through Altria’s purchase of a minority interest in JLI. At trial, Founding Partner Beth Wilkinson handled opening statements and examined multiple high-profile witnesses, including Altria’s current and former CEO, Altria’s general counsel, and both sides’ economic experts. WS Partner Moira Penza examined Altria’s scientists, and WS Partner James Rosenthal played a central role in strategy and legal briefing. After a single day of deliberation in October 2021, a jury delivered the first-ever verdict for Monsanto in litigation over whether the herbicide Roundup causes …

Wilkinson Stekloff Announces Promotions

Wilkinson Stekloff is pleased to announce that Cali Cope-Kasten has been promoted to partner, and Max Warren and Hayter Whitman have been promoted to counsel, effective January 1, 2022. All three attorneys have been with the firm since its founding in 2016. “Cases are won by tight-knit teams of smart, innovative, and highly skilled litigators united by a common commitment to excellence,” said WS Founding Partner Brian Stekloff. “These three lawyers have demonstrated those qualities in numerous, high-stakes trials and other cases throughout their careers. We are proud of the many successes they have achieved on behalf of our clients, and look forward to their continued contributions.” Cali Cope-Kasten has served as a key member of several trial teams, including most recently securing the groundbreaking verdict for Monsanto in Clark v. Monsanto, at which she was trial counsel. She represents corporate clients across a diverse set of industries, from pharmaceuticals …

Wilkinson Stekloff Wins First-Ever Jury Verdict for Monsanto in Roundup Mass Tort Litigation

After a single day of deliberation, a jury delivered the first-ever verdict for Monsanto yesterday in Clark v. Monsanto, a trial involving claims that the herbicide Roundup causes Non-Hodgkin Lymphoma. Wilkinson Stekloff Founding Partner Brian Stekloff first-chaired the trial; Associate Cali Cope-Kasten handled several witnesses, and Partner Kieran Gostin advised on all aspects of trial strategy. Clark was the fourth case in this mass tort to go to trial; the three previous trials resulted in verdicts against Monsanto ranging from $81 million to over $2 billion. Clark was also the first case involving a child plaintiff. The victory was the product of a comprehensive trial strategy. Shortly after being retained as lead trial counsel, Brian convinced the judge to “reverse bifurcate” the case into a first phase focused on causation and a second phase focused on liability and damages. The ruling marked the first time a state court judge has …

Wilkinson Stekloff Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

WASHINGTON – Wilkinson Stekloff is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Stekloff’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Stekloff won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Stekloff, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Stekloff, led by Kosta Stojilkovic …